Cart
sales@molnova.com
Aspartyl-alanyl-diketopiperazine
CAS No. 110954-19-3
Aspartyl-alanyl-diketopiperazine( Ampion | DA-DKP | Aspartyl-alanyl-diketopiperazine )
Catalog No. M26062 CAS No. 110954-19-3
Ampion is a known immunomodulatory molecule from the N terminus of human albumin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 260 | In Stock |
|
| 10MG | 410 | In Stock |
|
| 25MG | 678 | In Stock |
|
| 50MG | 954 | In Stock |
|
| 100MG | 1287 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAspartyl-alanyl-diketopiperazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmpion is a known immunomodulatory molecule from the N terminus of human albumin.
-
DescriptionAmpion is a known immunomodulatory molecule from the N terminus of human albumin.(In Vitro):Ampion can modulate the inflammatory immune response through a molecular pathway implicated in T- lymphocyte anergy.
-
In Vitro——
-
In Vivo——
-
SynonymsAmpion | DA-DKP | Aspartyl-alanyl-diketopiperazine
-
PathwayOthers
-
TargetOther Targets
-
RecptorA2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110954-19-3
-
Formula Weight186.167
-
Molecular FormulaC7H10N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (671.43 mM)
-
SMILESC[C@@H]1NC(=O)[C@H](CC(O)=O)NC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sullivan GW, et al. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999;180(5):1550-1560.
molnova catalog
related products
-
Pendimethalin
Pendimethalin is a herbicide with selective that controls annual grasses and certain annual broadleaf weeds.
-
Trastuzumab deruxtec...
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd).
-
Octahydroaminoacridi...
Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
